Bioanalysis

Papers
(The TQCC of Bioanalysis is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Meet the Editorial Board – An Interview with Min Meng and Transitions from Small Regional Labs to Global CRO35
Biomonitoring of Arsenic, Lead, Manganese and Mercury in Hair from a Presumably Exposed Uruguayan Child Population29
Peripheral blood mononuclear cells isolation from mouse and rabbit blood to quantify active nucleotide and define brincidofovir dose for smallpox28
Adopting ambient ionization mass spectrometry into bioanalytical laboratories26
Degradation of Vancomycin in External Quality Assessment Samples is a Factor to Underestimate Its Concentration25
Simple Method to Determine the Concentration and Incorporation Ratio of Ruthenium-Labeled Antibodies23
Volumetric Absorptive Microsampling as An Effective Microsampling Technique for LC–MS/MS Bioanalysis of Biomarkers in Drug Discovery23
Bioanalysis by LC-MS/MS and Preclinical Pharmacokinetic Interaction Study of Ribociclib and Oleanolic Acid23
Signal-to-noise Ratio to Assess Magnitude, Kinetics and Impact on Pharmacokinetics of the Immune Response to an Adalimumab Biosimilar20
Uncovering the Green Frontier: Harnessing Deep Eutectic Solvents for Sustainable Bioanalysis19
Biomarker Context-Of-Use: How Organizational Design Can Impact the Implementation of the Appropriate Biomarker Assay Strategy19
High-Sensitivity Workflow for LC–MS-Based Analysis of GALNAC-Conjugated Oligonucleotides: A Case Study18
HPPA as assay substrate for improved capturing of sample variability during cut point analyses in immunogenicity testing15
Patient-centric clinical trials: collaboration and innovation in bioanalytical and clinical operations14
Whole blood stability in bioanalytical method validation: updated recommendations from the European Bioanalysis Forum14
Determination of carbamazepine in fingerprints: a feasibility study to evaluate adherence in epilepsy patients13
Validation of Enantioseparation and Quantitation of an Active Metabolite of Abrocitinib in Human Plasma13
Determination of IQZ23 in Rat Plasma using LC-MS/MS: Consideration for Matrix Effect and Internal Standard Interference13
Handling Unstable Analytes: Literature Review and Expert Panel Survey by the Japan Bioanalysis Forum Discussion Group13
Recent advances in gold nanoparticle-based colorimetric aptasensors for chemical and biological analyses12
Strategy and Validation of a Nonclinical Generic Plug-and-Play Antidrug Antibody Method for Human Monoclonal Antibody Biotherapeutics12
The investigation of connection between anticoagulant therapy and vitamin K homologues in human determined by LC–MS/MS11
A comparison of branched DNA and reverse transcriptase quantitative polymerase chain reaction methodologies for quantitation of lipid nanoparticle encapsulated mRNA11
Simultaneous Measurement of Mouse and Human Albumin in Chimeric Mice with Humanized Livers11
Diversity and Inclusion in the Bioanalytical Industry: An Interview with Anahita Keyhani11
Comparison of Assay Formats Used for the Detection of Pre-Existing Anti-Drug Antibodies Against Monoclonal Antibodies11
Iron oxide nanozymes as versatile analytical tools: an overview of their application as detection technique11
Special Focus Issue - Covid-19: Bioanalytical Considerations, Contributions and Lessons – Part 210
A novel LC-MS/MS method for simultaneous estimation of chlordiazepoxide and clidinium in human plasma and its application to pharmacokinetic assessment10
Bioanalysis Rising Star Award 2024: interviews with the finalists10
An LC–MS/MS Method for Simultaneous Determination of LB-100 and Its Active Metabolite, Endothall, in Human Plasma9
Ligand-binding assays vs chromatographic platforms for oligonucleotide quantification9
Transforming drug discovery: the impact of AI and molecular simulation on R&D efficiency9
Validation of an LC–MS/MS method for the determination of sotorasib, a KRAS G12C inhibitor, in human plasma9
Special consideration: commentary on the 2025 FDA Bioanalytical Method Validation for Biomarkers9
Perspectives on a Flexible Strategy for the Management of Nonregulated Bioanalysis9
Considerations in Designing and Implementing a Bioanalytical Contract Research Organization Key Performance Indicator System8
Olympic Anti-Doping Laboratory: The Analytical Technological Road From 2016 Rio De Janeiro to 2021 Tokyo8
Western Blotting: Evolution of an Old Analytical Method To a New Quantitative Tool for Biomarker Measurements8
Determination of meropenem in capillary plasma microsamples using LC–MS/MS8
Method development for the quantification of lead levels in whole blood sampled on Mitra ® with VAMS ® tips by inductively coupled8
Highlights of the 13th Japan Bioanalysis Forum Symposium8
Bioanalysis of free antisense oligonucleotide payload from antibody–oligonucleotide conjugate by hybridization LC-MS/MS8
Highlights of the 15th Japan Bioanalysis Forum Symposium8
Inception and Development of a LC–MS/MS Assay for the Multiplexed Quantitation of Nine Human Drug Transporter Biomarkers8
Novel Isoelectric Target Depletion (ITaD) Protocol Reduces the Need for Specific Reagents for Immunogenicity Testing7
High Ionic Strength Dissociation Assay Reduces Dimeric Target Interference in Immunogenicity Testing7
Molecularly Imprinted Electrochemical Biosensor for Thrombin Detection by Comparing Different Monomers7
Special Focus Issue - Performing Flow Cytometry in Clinical Trials7
Comparison of multiple bioanalytical assay platforms for the quantitation of siRNA therapeutics7
Development and Validation of qPCR Methods for Nucleic Acid Biomarkers as a Drug Development Tool: Points to Consider7
A Sensitive, Robust and High-Throughput Isotope Dilution LC–MS/MS Method for Quantifying Three Folate Forms in Serum7
Critical Reagent Inventory Management System and Web Portal Specifically Optimized for Supporting External Clients7
DoE-assisted HPLC method development and validation of enzalutamide and repaglinide in rat plasma7
Validation of UV–Vis spectrophotometric colorimetric methods for Rifampicin quantification in PBS & biological matrices7
Upfront Acid Treatment with Low Final pH: The Development and Testing of a Novel Method to Improve Drug Tolerance in Antidrug Antibody Assays7
Determination of Amphetamines, Opioids, Cocaine Metabolites and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Using Biocompatible Solid-Phase Microextraction and Ultra-Performance LC–MS/MS7
Development of an LC-MS/MS assay to analyze a lipid-conjugated siRNA by solid phase extraction (SPE) in mouse plasma and tissue using a stable isotope labeled internal standard (SILIS)7
Internal standard variability: root cause investigation, parallelism for evaluating trackability and practical considerations7
An Eco-Friendly Ultra-Performance Liquid Chromatography–Mass Spectrometry Method for Quantification of Rivaroxaban and Ticagrelor in Rat Plasma: Grapefruit Interactions7
Quantitation of BCAA and BCKA in plasma and patient-centric dried blood microsamples in a clinical setting6
HPLC Method for Simultaneous Estimation of Paclitaxel and Baicalein: Pharmaceutical and Pharmacokinetic Applications6
Comparison of Requirements for Clinical Study of SARS-CoV-2 Antigen Test Kits in China, the USA and Europe6
Development and validation of bioanalytical methods to support clinical study of disitamab vedotin6
Perspective on High-Throughput Bioanalysis to Support In Vitro Assays in Early Drug Discovery6
Revolutionizing depression diagnosis: earwax analysis for cortisol and beyond6
Cytochrome P450 Enzymes: A Review on Drug Metabolizing Enzyme Inhibition Studies in Drug Discovery and Development6
Ocular Bioanalysis of Moxifloxacin and Ketorolac Tromethamine in Rabbit Lacrimal Matrix Using Liquid Chromatography–Tandem Mass Spectrometry6
Greener Bioanalytical Sample Preparation. What is Next?6
Determination of aloesone in rat plasma by LC–MS/MS spectrometry and its application in a pharmacokinetic study6
Effect of Chronopharmacology and Food on in Vivo Pharmacokinetic Profile of Mavacamten5
Development and validation of an LC–MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma5
Quantification of a promising JNK inhibitor and nitrovasodilator IQ-1 and its major metabolite in rat plasma by LC–MS/MS5
Development of LC–MS/MS Method for Cyanoenone Triterpenoid Determination to Support CNS Tissue Distribution Study5
Determination of Favipiravir in Human Plasma using Homogeneous Liquid–Liquid Microextraction followed by HPLC/UV5
Quantitative polymerase chain reaction in the bioanalytical laboratory and technical and scientific considerations for nonclinical and clinical assay characterization, validation and sample analysis5
Comparative pharmacokinetic study of Anisodamine Hydrobromide tablets and injection in septic acute lung injury rats5
Prediction of frozen virus stability based on degradation mechanisms, real-time data and modeling5
Critical reagent considerations for immunogenicity assay development for bispecific biotherapeutic candidates5
Development and validation of an ELISA method for quantification of the anti-HER3 antibody HMBD-001 in human serum5
Role of miRNA-21 in cancer and its application in electrochemical bioanalysis5
Single-Analyte Biomarker Assays for Pharmacodynamic or Safety Assessment During Biotherapeutic Development5
LC–MS/MS Methods for Direct Measurement of Sepiapterin and Tetrahydrobiopterin in Human Plasma and Clinical Applications5
LC–MS Bioanalysis of Protein Biomarkers and Protein Therapeutics in Formalin-Fixed Paraffin-Embedded Tissue Specimens5
Detection of Streptococcus anginosus in fecal samples using PCR-CRISPR /Cas12a system5
A Biomarker Assay Validation Approach Tailored to The Context of Use and Bioanalytical Platform5
Pitfalls in bioanalytical work with a Japanese CRO or sponsor: from a project risk management perspective4
Utilizing Droplet Digital Polymerase Chain Reaction for siRNA Quantitation in Rodent Plasma and Tissue Via Stem-Loop Reverse Transcription4
Characterization of Murine Lymphocyte Activation and Exhaustion Markers by a 14-Color Flow Cytometry Panel4
Novel assay format for total anti-adeno-associated virus antibody detection with low capsid consumption and built-in specificity control4
BiSim Tool: a binding simulation tool to aid and simplify ligand-binding assay design and development4
Development and validation of highly sensitive ligand binding assay to measure soluble DLL3 concentration in human serum4
Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing rats4
Bioanalysis of tucatinib and metabolite, and a five-way cross-validation to support clinical pharmacokinetic analysis4
LC-MS/MS method for co-estimation of doxorubicin and piperine: formulation development and pharmacokinetic studies4
A Validated Method for the Determination of Hematocrit in Dried Blood Spots Using Image Analysis4
High-resolution mass spectrometry for glycoproteomics4
Validated HPLC Method for Ceftriaxone from Dried Blood Spots for Pharmacokinetic Studies and Therapeutic Drug Monitoring in Neonatal Population4
Capillary Electrophoresis Mass Spectrometry for Metabolomics: Reflecting on the Next Steps4
Insights and Future Trends in Bioanalysis: An Interview With Jing Tu4
Validation and Application of Hybridization Liquid Chromatography-Tandem Mass Spectrometry Methods for Quantitative Bioanalysis of Antisense Oligonucleotides4
Development of pseudotyped VSV-SARS-CoV-2 spike variants for the assessment of neutralizing antibodies4
Harmonization of Vaccine Ligand Binding Assays Validation4
Bioanalytical tandem mass spectrometry method for cinacalcet in human plasma: green assessment with advanced metrics4
Rapid Development of Analytical Methods for Evaluating Pandemic Vaccines: A Covid-19 Perspective4
2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management4
Expanding Assay Range to Accommodate a Monoclonal Antibody Therapeutic Quantification in Blood and Cerebrospinal Fluid4
Thyroxine Biosensors: A Review on Progress and Challenges4
Development and validation of an antidrug antibody assay for TRK-950 using Melon™ gel and SPEAD pretreatment4
Cloud Solutions for GxP Laboratories: Considerations for Data Storage4
A Smartphone Digital Image Colorimetric Method Based on Nanoparticles for Determination of Lamotrigine4
Assessing linearity of vaccine immunogenicity assays: application and link with clinical endpoints4
A comprehensive LC–MS based study of factors influencing biotinylation of critical reagents4
Fabry Disease Biomarkers in Patients Switched From Enzyme-Replacement Therapy to Migalastat Oral Chaperone Therapy4
Pertinence of microsampling in various nonclinical and clinical studies: the ICH perspective3
LC–MS/MS Bioanalytical Method for Quantification of Binimetinib and Venetoclax, and their Pharmacokinetic Interaction3
Direct bioanalysis or indirect calculation of target engagement and free drug exposure: do we apply double standards?3
High-Throughput MS for Intact Protein Analysis3
Volumetric absorptive microsampling–LC–MS/MS assays for quantitation of giredestrant in dried human whole blood3
Quantifying skin permeation of a novel metformin lotion using modified hydrophilic interaction liquid chromatography3
Enantioselective electrochemical detection of a L-and D-serine at polyvinylpyrrolidone-modified platinum electrode3
Simultaneous quantitation of tigecycline, meropenem, polymyxin B in plasma, and protein-binding analysis in HSCT patients3
Multi-residue analysis method based on QuEChERS followed by ultra-high performance liquid chromatography coupled with diode-array detector for pesticides in human serum and breast milk3
LC-MS/MS Methods to quantify HCP002 in Human Plasma and Urine: Applications in a Pharmacokinetic Study3
Feasibility of using PALSAR technology as a signal amplifier for antibody bridging assay3
Measuring HSD17β13 protein turnover in mouse liver with D 2 O metabolic labeling and hybrid LC-MS3
Development of a validated novel bead extraction method for the detection of anti-PEG antibodies in human serum3
Artificial intelligence and blockchain in clinical trials: enhancing data governance efficiency, integrity, and transparency3
Pharmacokinetics and Toxicity Considerations for Antibody–drug Conjugates: An Overview3
Blood Cell Quantification on Dry Blood Samples: Toward Patient-Centric Complete Blood Counts3
LC–MS/MS method for quantification of raspberry ketone in rat plasma: application to preclinical pharmacokinetic studies3
High-sensitivity Quantification of Antisense Oligonucleotides for Pharmacokinetic Characterization3
Thalidomide Measurement in Plasma and Dried Plasma Spot by SPE Combined with UHPLC-MS/MS for Therapeutic Drug Monitoring3
Analytical Considerations to Support Expeditious Formulation Development of Vaccines3
Development and Validation of Reversed-Phase-HPLC Method for Simultaneous Quantification of Fulvestrant and Disulfiram in Liposomes3
2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; 3
Re-thinking the current paradigm for clinical immunogenicity assessment: an update from the discussion in the European Bioanalysis Forum3
Lessons Learned from Regulatory Submissions Involving Endogenous Therapeutic Analyte Bioanalysis3
Research progress of N -nitrosamine detection methods: a review3
Accelerating isotope dilution LC-MS-based desmosine quantification for estimating elastin turnover3
Green HPLC method for determination of paracetamol and ibuprofen in human plasma: applications to pharmacokinetics3
A Bioanalytical Screening Method for Enterococcus faecalis RNPP-type Quorum Sensing Peptides in Murine Feces3
Quantification of MDR-TB drug JBD0131 and its metabolite in plasma via UPLC-MS/MS: application in first-in-human study3
Moving into the cloud: a summary from a European Bioanalysis forum workshop on introducing cloud applications in bioanalytical laboratories3
Technique Development of High-Throughput and High-Sensitivity Sample Preparation and Separation for Proteomics3
With Great Power Comes Great Responsibility: High-Dimensional Spectral Flow Cytometry to Support Clinical Trials3
Welcome to Volume 14 of Bioanalysis3
Large Molecule Bioanalysis by LC–MS: Beyond Simply Quantifying3
Free serum concentrations of antibiotics determined by ultrafiltration: extensive evaluation of experimental variables3
Advances in green sample preparation methods for bioanalytical laboratories focusing on drug analysis3
Integrating metering capabilities to increase the utility of self-collected, dried samples3
Comparison of Liquid–Liquid Extraction, Microextraction and Ultrafiltration for Measuring Free Concentrations of Testosterone and Phenytoin3
China's NMPA Perspective on the Clinical Performance of SARS-CoV-2 Antigen Test Reagents3
Testing in the Workplace: Finding a Path Through a Pandemic3
Singlicate analysis in ADA assays: comparing assay performance in duplicate and singlicate formats3
Simultaneous estimation of donepezil and quercetin using ultra high performance liquid chromatography: pharmaceutical and pharmacokinetic applications in Alzheimer’s disease3
Nitrosamine Impurities: from Raw Materials to Final Drug Product3
Bioanalysis Rising Star Award 2023: announcing our finalists3
A Validated Capillary Microsampling Liquid Chromatography–Tandem Mass Spectrometry Method for Quantification of Antisense Oligonucleotides in Mouse Serum3
2024 White paper on recent issues in bioanalysis: Impact of LDT in US and IVDR in EU; AI/ML for High Parameter Flow Cytometry; The rise of Olink Technology; CDx for AAV Gene Therapies; Integrative Bio3
0.065708160400391